Alnylam Licenses RNAi Patent Family to Sigma-Aldrich

Jul 19, 2005

NEW YORK, July 19 (GenomeWeb News) - Sigma-Aldrich has licensed a number of RNA interference patents known as the Kreutzer-Limmer patent family from Alnylam Pharmaceuticals to provide research products and services, the companies said today.

The patents cover short interfering RNAs and their use to mediate RNA interference in mammalian cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Main menu